Outpatient hemodialysis facilities participating in the Centers for Medicare and Medicaid Services (CMS) End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) must submit their Q4 2022 Dialysis Event data to NHSN
What Do I Need to Know?
CMS Waivers, Flexibilities, and the Transition Forward from the COVID-19 Public Health Emergency
Smiths Medical Recalls Certain CADD System Administration Sets and Cassette Reservoirs for Issues Causing Delay, Interruption, or Under-Delivery of Therapy
Recalled Product
The Centers for Medicare & Medicaid Services (CMS) EQRS submission deadlines for the calendar year (CY) 2023 reporting months are listed below.
DID YOU KNOW THAT CMS RECENTLY UPDATED QIP TO INCLUDE A MEASURE OF VACCINATION RATES AMONG DIALYSIS HEALTHCARE PERSONNEL?
This is a 2-part measure:
The Centers for Medicare & Medicaid Services (CMS) will release the Payment Year (PY) 2023 End-Stage Renal Disease Quality Incentive Program (ESRD QIP) Final Performance Score Reports (PSRs) and Performance Score Certificates (PSCs).
HC3 is closely tracking hacktivist groups which have previously affected a wide range of countries and industries, including the United States Healthcare and Public Health (HPH) sector.
Once the emergency ends, Medicare beneficiaries generally will face out-of-pocket costs for at-home testing and all treatment. However, vaccines will continue to be covered at no cost, as will testing ordered by a health care provider.
Medtronic is recalling the Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters due to a potential catheter hub defect that may cause leaks across the catheter’s tubes.